NCT01992692View on ClinicalTrials.gov

Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Parkinson's Disease
Trial Locations (1)

200433

Department of Anesthesiology, Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT01992692 - Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter